Preliminary prospective study of the endocrinology of conception cycles and early pregnancy in women with antiphospholipid syndrome treated with low molecular weight heparin

Fertil Steril. 2006 Jan;85(1):165-70. doi: 10.1016/j.fertnstert.2005.07.1288.

Abstract

Objective: To examine whether there were any differences in the endocrinological profiles during conception cycle and early pregnancy between a control group and women with a history of recurrent miscarriage that was caused by antiphospholipid syndrome and that was treated with aspirin and low molecular weight heparin.

Design: Prospective observational study.

Setting: Recurrent Miscarriage Clinic, Department of Obstetrics and Gynaecology in a tertiary care centre.

Patient(s): Five women with recurrent pregnancy loss were recruited as cases, whereas another five women having natural cycle donor insemination were used as control.

Intervention(s): Serial measurement of serum beta-hCG, activin A, and inhibin A was performed from postovulatory day 12 until 11 weeks of gestation.

Main outcome measure(s): Comparison of levels of beta-hCG, activin A, and inhibin A at the time of conception onwards till 11 weeks in the two groups.

Result(s): There were no significant differences between the two groups.

Conclusion(s): There does not appear to be any obvious endocrinological alteration in the conception cycle of women with antiphospholipid syndrome compared with a control group. Furthermore, the initiation of heparin does not produce a significant change in activin A and inhibin A levels.

Publication types

  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Abortion, Habitual / blood
  • Abortion, Habitual / etiology*
  • Activins / blood
  • Adult
  • Anticoagulants / therapeutic use*
  • Antiphospholipid Syndrome / blood
  • Antiphospholipid Syndrome / complications
  • Antiphospholipid Syndrome / drug therapy*
  • Aspirin / therapeutic use
  • Case-Control Studies
  • Chorionic Gonadotropin, beta Subunit, Human / blood
  • Female
  • Heparin, Low-Molecular-Weight / therapeutic use*
  • Humans
  • Inhibin-beta Subunits / blood
  • Inhibins / blood
  • Pilot Projects
  • Pregnancy
  • Pregnancy Outcome
  • Pregnancy Trimester, First
  • Prospective Studies

Substances

  • Anticoagulants
  • Chorionic Gonadotropin, beta Subunit, Human
  • Heparin, Low-Molecular-Weight
  • activin A
  • inhibin A
  • Activins
  • Inhibins
  • Inhibin-beta Subunits
  • Aspirin